Literature DB >> 10823846

Efficient DNA transfection mediated by the C-terminal domain of human immunodeficiency virus type 1 viral protein R.

A Kichler1, J C Pages, C Leborgne, S Druillennec, C Lenoir, D Coulaud, E Delain, E Le Cam, B P Roques, O Danos.   

Abstract

Viral protein R (Vpr) of human immunodeficiency virus type 1 is produced late in the virus life cycle and is assembled into the virion through binding to the Gag protein. It is known to play a significant role early in the viral life cycle by facilitating the nuclear import of the preintegration complex in nondividing cells. Vpr is also able to interact with nucleic acids, and we show here that it induces condensation of plasmid DNA. We have explored the possibility of using these properties in DNA transfection experiments. We report that the C-terminal half of the protein (Vpr(52-96)) mediates DNA transfection in a variety of human and nonhuman cell lines with efficiencies comparable to those of the best-known transfection agents. Compared with polylysine, a standard polycationic transfection reagent, Vpr(52-96) was 10- to 1,000-fold more active. Vpr(52-96)-DNA complexes were able to reach the cell nucleus through a pH-independent mechanism. These observations possibly identify an alternate pathway for DNA transfection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10823846      PMCID: PMC112026          DOI: 10.1128/jvi.74.12.5424-5431.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Evidence for the role of proteoglycans in cation-mediated gene transfer.

Authors:  K A Mislick; J D Baldeschwieler
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

2.  Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity.

Authors:  J He; S Choe; R Walker; P Di Marzio; D O Morgan; N R Landau
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

3.  Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000-fold.

Authors:  O Boussif; M A Zanta; J P Behr
Journal:  Gene Ther       Date:  1996-12       Impact factor: 5.250

4.  The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB.

Authors:  I Agostini; J M Navarro; F Rey; M Bouhamdan; B Spire; R Vigne; J Sire
Journal:  J Mol Biol       Date:  1996-09-06       Impact factor: 5.469

Review 5.  HIV-1, Vpr and the cell cycle.

Authors:  M Emerman
Journal:  Curr Biol       Date:  1996-09-01       Impact factor: 10.834

6.  Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat.

Authors:  L Wang; S Mukherjee; F Jia; O Narayan; L J Zhao
Journal:  J Biol Chem       Date:  1995-10-27       Impact factor: 5.157

7.  The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle.

Authors:  J B Jowett; V Planelles; B Poon; N P Shah; M L Chen; I S Chen
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

8.  Putative role of chloroquine in gene transfer into a human hepatoma cell line by DNA/lactosylated polylysine complexes.

Authors:  P Erbacher; A C Roche; M Monsigny; P Midoux
Journal:  Exp Cell Res       Date:  1996-05-25       Impact factor: 3.905

9.  Extracellular addition of a domain of HIV-1 Vpr containing the amino acid sequence motif H(S/F)RIG causes cell membrane permeabilization and death.

Authors:  I G Macreadie; C K Arunagiri; D R Hewish; J F White; A A Azad
Journal:  Mol Microbiol       Date:  1996-03       Impact factor: 3.501

10.  Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr.

Authors:  P Di Marzio; S Choe; M Ebright; R Knoblauch; N R Landau
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

View more
  18 in total

1.  Histidine-rich amphipathic peptide antibiotics promote efficient delivery of DNA into mammalian cells.

Authors:  Antoine Kichler; Christian Leborgne; Josefine März; Olivier Danos; Burkhard Bechinger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-31       Impact factor: 11.205

Review 2.  Applying horizontal gene transfer phenomena to enhance non-viral gene therapy.

Authors:  Jacob J Elmer; Matthew D Christensen; Kaushal Rege
Journal:  J Control Release       Date:  2013-08-30       Impact factor: 9.776

3.  Characterization of the gene transfer process mediated by histidine-rich peptides.

Authors:  Antoine Kichler; Christian Leborgne; Olivier Danos; Burkhard Bechinger
Journal:  J Mol Med (Berl)       Date:  2006-11-17       Impact factor: 4.599

Review 4.  The nuclear pore complex: the gateway to successful nonviral gene delivery.

Authors:  Marieke A E M van der Aa; Enrico Mastrobattista; Ronald S Oosting; Wim E Hennink; Gerben A Koning; Daan J A Crommelin
Journal:  Pharm Res       Date:  2006-03-15       Impact factor: 4.200

5.  Critical implication of the (70-96) domain of human immunodeficiency virus type 1 Vpr protein in apoptosis of primary rat cortical and striatal neurons.

Authors:  Emmanuelle N Sabbah; Bernard P Roques
Journal:  J Neurovirol       Date:  2005-12       Impact factor: 2.643

6.  A protein ballet around the viral genome orchestrated by HIV-1 reverse transcriptase leads to an architectural switch: from nucleocapsid-condensed RNA to Vpr-bridged DNA.

Authors:  Sébastien Lyonnais; Robert J Gorelick; Fatima Heniche-Boukhalfa; Serge Bouaziz; Vincent Parissi; Jean-François Mouscadet; Tobias Restle; Jose Maria Gatell; Eric Le Cam; Gilles Mirambeau
Journal:  Virus Res       Date:  2012-09-24       Impact factor: 3.303

Review 7.  Roles of Vpr and Vpx in modulating the virus-host cell relationship.

Authors:  Vicente Planelles; Edward Barker
Journal:  Mol Aspects Med       Date:  2010-06-15

8.  The C-terminal domain of the HIV-1 regulatory protein Vpr adopts an antiparallel dimeric structure in solution via its leucine-zipper-like domain.

Authors:  Sarah Bourbigot; Hervé Beltz; Jérôme Denis; Nelly Morellet; Bernard P Roques; Yves Mély; Serge Bouaziz
Journal:  Biochem J       Date:  2005-04-15       Impact factor: 3.857

9.  The (52-96) C-terminal domain of Vpr stimulates HIV-1 IN-mediated homologous strand transfer of mini-viral DNA.

Authors:  Julien Bischerour; Patrick Tauc; Hervé Leh; Hugues de Rocquigny; Bernard Roques; Jean-François Mouscadet
Journal:  Nucleic Acids Res       Date:  2003-05-15       Impact factor: 16.971

10.  Modulating the activity of the channel-forming segment of Vpr protein from HIV-1.

Authors:  Chin-Pei Chen; Clemens Kremer; Peter Henklein; Ulrich Schubert; Rainer H A Fink; Wolfgang B Fischer
Journal:  Eur Biophys J       Date:  2009-07-24       Impact factor: 1.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.